VitMode

Phosphatidylserine and Post-Exercise Cortisol: Does This Supplement Really Blunt Training Stress

Phosphatidylserine is often marketed to athletes and people training intensely as a way to "calm down" cortisol after a workout and speed up recovery. Behind this claim stands a specific double-blind, placebo-controlled crossover study — small, but methodologically solid. We take a close look at exactly what it showed, and what it didn't, before you decide on this fairly costly supplement.

MNMichał NowakSeptember 2, 202611 min read
Table of contents

Phosphatidylserine — a membrane phospholipid that made its way into sports supplementation

Phosphatidylserine (PS) is a phospholipid that's a natural component of cell membranes, present in especially large amounts in nervous tissue. For years it was studied mainly in the context of cognitive function and memory in older adults, but in recent decades it has also carved out a separate, well-defined niche in sports supplementation — as an agent meant to limit the excessive rise in cortisol after intense physical exertion. That second area of application is the subject of this article.

Cortisol is a stress hormone secreted by the adrenal glands, whose level physiologically rises during and after intense exercise — a normal, necessary part of the body's response to training load. The problem arises only with chronically, excessively elevated cortisol, seen in people training too intensely without adequate recovery, since it can promote muscle tissue breakdown, weaken immunity, and worsen sleep quality. It's this relationship that underlies the hypothesis that a substance blunting the post-exercise cortisol rise could support recovery and reduce the risk of overtraining.

What the 2008 Starks et al. study showed

The effects of phosphatidylserine on endocrine response to moderate intensity exercise

Early-stage evidence

Starks MA, Starks SL, Kingsley M, Purpura M, Jäger R · Journal of the International Society of Sports Nutrition · 2008

A double-blind, placebo-controlled, crossover study included 10 healthy men who took 600 mg of phosphatidylserine daily or placebo for 10 days. Blood samples were taken at rest, after a 15-minute moderate-intensity exercise protocol on a cycle ergometer (five 3-minute stages of increasing load from 65% to 85% VO2max), and during a 65-minute passive recovery period. Mean peak cortisol concentration and area under the curve (AUC) were lower after PS supplementation (by 39% and 35%, respectively) compared with placebo (p<0.05). PS supplementation also increased the area under the curve for the testosterone-to-cortisol ratio by 184% relative to placebo (p<0.05). PS and placebo did not differ significantly in lactate or growth hormone levels.

View study

In other words: in the same ten men, compared against themselves under two different conditions (PS versus placebo), the cortisol response to an identical exercise protocol was markedly milder after ten days of taking phosphatidylserine. Using a crossover design (each participant serving as their own control) is a strength of this study — it eliminates some of the between-person variability that complicates interpretation of studies comparing two entirely different groups of participants.

This is one of several consistent studies on this topic

The Starks et al. result isn't an outlier — earlier studies from the same and related research teams, using different doses (300 to 800 mg daily) and different phosphatidylserine sources (soy-derived and bovine cortex-derived), also showed blunting of the post-exercise cortisol rise. This strengthens confidence in the overall direction of the effect, though each of these studies individually had a very small number of participants.

Why sample size (n=10) is such a significant limitation

A very small sample, despite a solid design

The study included only ten participants — all healthy, young men. Even with a well-designed crossover protocol, such a small sample size means results may be susceptible to random fluctuation, and confidence intervals around the true effect size are wide, even if the result itself is statistically significant. The effect observed in this specific group of ten men doesn't necessarily fully reflect the average effect in the general population, including women, older adults, or elite athletes training under an entirely different load regimen.

This is one reason we classify the strength of this evidence as preliminary, despite the strong points of the study's design itself (randomization, blinding, placebo control, crossover design). A solid methodology doesn't fully compensate for a small number of participants — both elements are needed simultaneously to speak of strong evidence.

Mechanism: why a phospholipid would affect the stress axis

The mechanistic hypothesis linking phosphatidylserine to cortisol blunting invokes its role in regulating the hypothalamic-pituitary-adrenal (HPA) axis — the hormonal system responsible for the body's response to stress, including the physical stress of exercise. Phosphatidylserine is a cofactor for enzymes involved in signal transmission in neuronal cell membranes, which theoretically could modulate signaling within this axis, limiting excessive cortisol secretion in response to a stressor like intense exercise.

It's worth honestly noting, though, that the exact mechanism by which oral supplementation would actually alter HPA axis function at the molecular level in humans hasn't been fully elucidated — the observed effect (lower post-exercise cortisol) is better documented than the mechanism that would explain it.

Myth vs. fact: is phosphatidylserine a cortisol "off switch"

Myth

Phosphatidylserine completely blocks the rise in cortisol after training, so you can train more intensely without risking overtraining.

Fact

The Starks et al. study showed a blunting, not a complete blocking, of the post-exercise cortisol rise — peak concentration and area under the curve were lower by 39% and 35% respectively, but cortisol still rose in response to exercise, just to a lesser degree. Phosphatidylserine isn't a substitute for adequate recovery, sleep, and training load distribution — it's at most a potential, minor modifier of one of many variables affecting recovery.

This distinction has practical relevance for people who train: supplementing with phosphatidylserine, even if it works as this study suggests, doesn't remove the need to plan training volume and intensity in a way that accounts for the body's actual capacity to recover.

Practical guidance on dosing and expectations

What to know before reaching for phosphatidylserine for post-workout recovery

  • The dose used in this study was 600 mg daily for 10 days, whether split or as a single dose — other studies tested doses from 300 to 800 mg daily with a similar direction of effect
  • The effect was observed after several days of supplementation, not after a single dose taken right before training — this is a supplement requiring some consistency, not occasional use
  • Soy-derived phosphatidylserine is the currently preferred source in commercially available supplements, for safety reasons, compared with the bovine cortex-derived form used in some older studies
  • This supplement can be relatively costly on a monthly basis — worth weighing against the limited, preliminary strength of the evidence before committing to longer-term supplementation
  • It's not a substitute for the basic pillars of recovery: sleep, adequate calorie and protein intake, and sensible distribution of training volume over time

Limitations of this evidence

A single, small study — promising, but insufficient for strong conclusions

Early-stage evidence

The study discussed has a solid methodological design (randomization, blinding, placebo control, crossover), but includes only ten participants, exclusively healthy young men, subjected to one specific moderate-intensity exercise protocol. It's unknown whether the result would translate to women, older adults, elite athletes, or other types of exercise (e.g., high-intensity resistance training instead of aerobic effort on a cycle ergometer). Larger, independently replicated studies in diverse populations are needed before this effect can be considered strongly confirmed.

QuestionShort answer
Does phosphatidylserine lower post-exercise cortisol?Yes, in one RCT — peak cortisol lower by 39%, AUC lower by 35% than placebo
Is this a large, convincing study?No — a solid design, but only 10 participants; we rate the effect as preliminary
What dose was tested?600 mg daily for 10 days in this specific study; other work tested 300–800 mg daily
Does this replace adequate recovery?No — the effect is a partial blunting of the cortisol response, not a substitute for sleep and training planning
Is it worth investing in this supplement?That's an individual decision — the evidence is promising but preliminary, and the supplement can be costly

Phosphatidylserine and post-exercise cortisol at a glance

Our editorial recommendation

Phosphatidylserine falls into that category of sports supplements where the biological mechanism is plausible and at least one well-designed study shows a specific, measurable effect — but the scale of that study is too small to speak of certainty. "Promising, but requiring confirmation" is the honest characterization, not "proven effect," and that's exactly how to approach the decision to supplement.

Ten men and one exercise protocol aren't enough to declare phosphatidylserine a breakthrough in post-training recovery — but they're enough to take the topic seriously and wait for larger studies, rather than dismissing it outright.

Michał Nowak, VitMode editorial team

Frequently asked questions

The study underlying this article included only ten healthy, young men — it's unknown whether the effect is equally clear in women, older adults, or athletes at a different training level. Individual response may vary, and the available data are too limited to predict this precisely.

In the study discussed, the effect was assessed after 10 days of regular supplementation, not after a single dose. This suggests that if the effect is real, it requires some consistency of use rather than an occasional dose taken right before a workout.

Earlier studies used both forms and observed a similar direction of effect, but soy-derived phosphatidylserine is currently preferred in commercially available supplements for safety reasons (risk of prion transmission with animal-derived forms). There are no solid studies directly comparing the effectiveness of both forms for cortisol blunting.

Yes, that's a separate and better-studied area of phosphatidylserine's use, concerning mainly cognitive function in older adults — but it's a different topic from the effect on post-exercise cortisol discussed in this article, based on separate studies with different populations and protocols.

The study discussed evaluated only hormonal parameters (cortisol, testosterone, growth hormone, lactate), not sports performance or muscle recovery rate directly. A link between a blunted cortisol response and a real improvement in performance or recovery is plausible, but wasn't directly measured in this particular study.

The study discussed reported no significant adverse effects at a dose of 600 mg daily for 10 days. As with any supplement, caution is warranted when combining it with other agents affecting blood clotting, and longer-term supplementation is worth discussing with a doctor, especially with existing health conditions.

Several smaller studies from the same and related research teams, using different doses and forms of phosphatidylserine, showed a similar direction of effect, which increases confidence in the overall hypothesis. However, there's no large, fully independent meta-analysis combining these results into one strong assessment — the topic remains at the stage of preliminary evidence.

Sources

MN

Michał Nowak

MSc in Clinical Dietetics, certified sports-nutrition coach

Michał specializes in metabolic nutrition, intermittent fasting and sports supplementation.

Related articles

Related knowledge base entries

Comments (2)

  • KW

    Kasia W. 2 weeks ago

    Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.

  • MT

    Marek T. a month ago

    Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.